sulindac
Sign in to saveSulindac is a nonsteroidal anti-inflammatory drug (NSAID) of the arylalkanoic acid class that is marketed as Clinoril. Imbaral is another name for this drug. Its name is derived from sul(finyl)+ ind(ene)+ ac(etic acid) It was patented in 1969 and approved for medical use in 1976.
Article
7 sectionsContents
- Medical uses
- Adverse effects
- Society and culture
- Litigation
- Synthesis
- References
- External links
{{Drugbox | Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 470474499 | IUPAC_name = {(1Z)-5-fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-indene-3-yl}acetic acid | image = Sulindac structure.svg | image_class = skin-invert-image
| tradename = Clinoril | Drugs.com = | MedlinePlus = a681037 | pregnancy_AU = C | pregnancy_US = C | legal_AU = S4 | legal_UK = POM | legal_US = Rx-only | routes_of_administration = By mouth